The conversation started with a look at where NIH SBIR grant funding — one of the earliest types of funding for a new company — flows geographically across the nation.
The follow-on piece traced medical device start-ups from ‘first money in,’ and considered in detail the discrepancy between where Angel-funding was being deployed and where formal venture capital investments were being made.
Image: https://medium.com
